- Home
- ABSI vs AGL Comparison
ABSI vs AGL Comparison
Compare ABSI & AGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.91
HOLD
Current Price
$0.43
Company Overview
Basic Information| Metric | ABSI | AGL |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Managed Health Care |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.9M | 422.9M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ABSI | AGL |
|---|---|---|
| Price | $2.91 | $0.43 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 14 |
| Target Price | ★ $7.98 | $2.66 |
| AVG Volume (30 Days) | 3.0M | ★ 4.7M |
| Earning Date | 03-24-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $4,534,000.00 | ★ $5,932,576,000.00 |
| Revenue This Year | $10.72 | N/A |
| Revenue Next Year | $313.07 | $5.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.01 | $0.34 |
| 52 Week High | $5.23 | $6.08 |
Technical Indicators
Market Signals| Indicator | ABSI | AGL |
|---|---|---|
| Relative Strength Index (RSI) | 55.02 | 36.29 |
| Support Level | $2.45 | $0.34 |
| Resistance Level | $3.29 | $0.73 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 71.35 | 0.00 |
Price Performance
Historical Comparison ABSI
AGL
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About AGL agilon health inc.
Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.